Traws Pharma (TRAW) Proxy filing summary

Executive summary

• Annual meeting scheduled for July 8, 2026, with voting open until July 7, 2026, at 11:59 PM ET.

• Shareholders can access proxy materials online or request paper/email copies by June 24, 2026.

• Meeting will be held virtually, allowing remote participation and voting.

Voting matters and shareholder proposals

• Election of seven directors, with nominees including Iain Dukes, Werner Cautreels, Trafford Clarke, John Leaman, Nikolay Savchuk, M. Teresa Shoemaker, and Jack E. Stover.

• Proposal to amend the 2021 Incentive Compensation Plan to increase available shares by 2,000,000 and make administrative changes.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Approval sought for issuance of common stock upon exercise of Series B and C Warrants issued under a Securities Purchase Agreement dated April 15, 2026.

• Proposal to allow adjournment of the meeting if additional proxy solicitation is needed.

Board of directors and corporate governance

• Board recommends approval of all proposals presented for shareholder vote.

• Director nominees represent a mix of scientific, medical, and executive backgrounds.